ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,892, issued on Sept. 23, was assigned to XSPRAY PHARMA AB (Solna, Sweden).
"Pharmaceutical compositions comprising nilotinib" was invented by Andreas Fischer (Uppsala, Sweden) and Thomas Andersson (Segeltorp, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a composition comprising: an amorphous solid dispersion (ASD) comprising nilotinib and at least one polymeric stabilizing and matrix-forming component; and at least one solid organic acid in admixture with the ASD, and uses thereof in the treatment of proliferative disorder."
The patent was filed on Nov. 8, 2024, under Application No. 18/941,137.
*For further informati...